Therapy News and Research

RSS

Pneumococcal pneumonia mortality falling

Between 2000 and 2013 there has been an increase in the early prescription of antibiotics and use of combination therapy in patients with pneumococcal pneumonia, researchers report.

28 Jul 2014

Medicare turns up heat on fraud investigations

One U.S. attorney in South Dakota says such cases will be one of the fastest-growing areas of criminal investigations, while some providers are crying foul.

28 Jul 2014

Cardioxyl reports positive results from CXL-1427 Phase I trial for treatment of ADHF

Cardioxyl Pharmaceuticals, Inc. announced today the positive results of a clinical trial demonstrating that CXL-1427, a novel potential treatment for acute decompensated heart failure (ADHF), was well tolerated in healthy volunteers.

28 Jul 2014

Envarsus gets marketing authorization from EC for treatment of kidney and liver transplant patients

Veloxis Pharmaceuticals A/S and Chiesi Farmaceutici S.p.A. today announced that the European Commission (EC) has granted marketing authorization for Envarsus for the prevention of organ rejection in adult kidney and liver transplant patients in the European Union.

28 Jul 2014

Adopting a comprehensive and integrative healing strategy for cancer

The cancer drugs, radiation therapy and cancer surgery available today help millions of people survive their cancer.

27 Jul 2014

Fitnessedge.net adds new articles on using hGH peptides for anti-aging, hGH replacement therapy

Fitnessedge.net, a website that is devoted to offering readers the most up-to-date information about various weight loss programs, has just added some new and educational articles on using hGH peptides for anti-aging and hGH replacement therapy.

26 Jul 2014

Trinidad & Tobago Ministry of Health approves hepatitis C drug telaprevir

The Chemistry, Food & Drugs Division of the Trinidad & Tobago Ministry of Health approved the introduction of Telaprevir to the market, an innovative therapy that significantly increases the cure rate from Hepatitis C, and it is indicated for patients infected with the genotype 1 virus. Telaprevir is available in Trinidad under the trade brand INCIVO®.

26 Jul 2014

SAVE Medicare Home Health Act replaces unprecedented rebasing cuts

Home health leaders today said that growing support for the Securing Access Via Excellence (SAVE) Medicare Home Health Act – introduced last week by Representatives Greg Walden (OR-2) and Tom Price (GA-6) – underscores the importance of legislation to repeal the 14 percent, four-year rebasing cuts instituted by the Centers for Medicare and Medicaid Services (CMS) on January 1.

26 Jul 2014

Pediatrician currently utilizes Quotient ADHD test on patients

Attention Deficit Hyperactivity Disorder (ADHD) is a common childhood condition characterized by more than normal difficulty with focus, behavior control, impulsivity and hyperactivity.

26 Jul 2014

Massage therapy can alleviate symptoms of multiple sclerosis

An estimated 2.3 million people worldwide live with multiple sclerosis (MS) each day, a debilitating disease that can often cause severe pain, muscle spasms, poor circulation, anxiety, stress and clinical depression.

26 Jul 2014

Viewpoints: Ryan's 'thoughtful blueprint' to end poverty; GOP challenges after health law ruling

The Republican chairman of the House Budget Committee today released a thoughtful blueprint for overhauling $800 billion worth of U.S. anti-poverty programs.

26 Jul 2014

CanTx, Novogen name two key CMOs to manufacture clinical batches of anti-cancer drug Cantrixil

Oncology drug developer, CanTx Inc., and its parent company, Novogen Ltd., today announced that they have named two key contract manufacturing organizations (CMOs) to produce clinical batches of the experimental anti-cancer drug, Cantrixil.

26 Jul 2014

Researchers exploring ways to stimulate patients' immune system to attack tumors

Researchers at Dartmouth-Hitchcock Norris Cotton Cancer Center are exploring ways to wake up the immune system so it recognizes and attacks invading cancer cells. Tumors protect themselves by tricking the immune system into accepting everything as normal, even while cancer cells are dividing and spreading.

26 Jul 2014

EGPAF applauds new licensing agreement to improve access to HIV medication for children

The Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) applauds the new licensing agreement between the Medicines Patent Pool (MPP) and Gilead Sciences, Inc. to improve access to tenofovir alafenamide fumarate (TAF), a promising new HIV medication.

26 Jul 2014

Study investigates ventilation strategies used during anaesthesia given for abdomen surgery

A multi-centre study at 30 centres across Europe, North and South America involving a total of 900 test subjects has investigated various ventilation strategies currently used during anaesthesia given for surgical procedures involving the abdomen to see just how effective they are.

26 Jul 2014

XPro1595 drug can protect vulnerable neurons, reduce motor deficits in Parkinson's model

An experimental anti-inflammatory drug can protect vulnerable neurons and reduce motor deficits in a rat model of Parkinson's disease, researchers at Emory University School of Medicine have shown.

26 Jul 2014

Researchers demonstrate novel approach in cervical cancer prevention

A study published online in the International Journal of Cancer earlier this month describes a novel approach to preventing cervical cancer based on findings showing successful reduction in the risk of cervical cancer after removal of a discrete population of cells in the cervix.

26 Jul 2014

Continuous antibiotics for children with antenatal hydronephrosis not necessary, study finds

Up to 5 percent of all prenatal ultrasounds uncover antenatal hydronephrosis, or enlarged kidneys, the most commonly detected prenatal abnormality in the United States. Many children with this abnormality are treated continually with preventive antibiotics for the first few years of life with the hopes of preventing the condition's associated urinary tract infections.

25 Jul 2014

Galmed reports net loss of $3.9 million for six months ended June 30, 2014

Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company focused on the development and commercialization of a once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones, today announced financial results for the period ended June 30, 2014.

25 Jul 2014

EMA recommends full marketing approval for IMBRUVICA in the European Union

Pharmacyclics, Inc. today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency issued a positive opinion recommending the granting of full marketing approval for IMBRUVICA (ibrutinib) in the European Union.

25 Jul 2014

Therapy News and Research

Pneumococcal pneumonia mortality falling

Medicare turns up heat on fraud investigations

Cardioxyl reports positive results from CXL-1427 Phase I trial for treatment of ADHF

Envarsus gets marketing authorization from EC for treatment of kidney and liver transplant patients

Adopting a comprehensive and integrative healing strategy for cancer

Fitnessedge.net adds new articles on using hGH peptides for anti-aging, hGH replacement therapy

Trinidad & Tobago Ministry of Health approves hepatitis C drug telaprevir

SAVE Medicare Home Health Act replaces unprecedented rebasing cuts

Pediatrician currently utilizes Quotient ADHD test on patients

Massage therapy can alleviate symptoms of multiple sclerosis

Viewpoints: Ryan's 'thoughtful blueprint' to end poverty; GOP challenges after health law ruling

CanTx, Novogen name two key CMOs to manufacture clinical batches of anti-cancer drug Cantrixil

Researchers exploring ways to stimulate patients' immune system to attack tumors

EGPAF applauds new licensing agreement to improve access to HIV medication for children

Study investigates ventilation strategies used during anaesthesia given for abdomen surgery

XPro1595 drug can protect vulnerable neurons, reduce motor deficits in Parkinson's model

Researchers demonstrate novel approach in cervical cancer prevention

Continuous antibiotics for children with antenatal hydronephrosis not necessary, study finds

Galmed reports net loss of $3.9 million for six months ended June 30, 2014

EMA recommends full marketing approval for IMBRUVICA in the European Union

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News